Results 41 to 50 of about 2,513 (151)

Fertility-Sparing Management of Grade 2 Endometrioid Endometrial Adenocarcinoma Without Progesterone Receptor Expression: A Case Report

Case Reports in Obstetrics and Gynecology
Managing G2 endometrioid endometrial adenocarcinoma without progesterone receptor (PR) expression presents significant challenges, particularly when considering fertility preservation.
Luiz Felipe Lessa Ortiz, Rafael Dyer Rodrigues de Moraes, Renan Ribeiro e Ribeiro, Caio Bosquê Hidalgo Ribeiro, Amanda Lino De Faria Lessa, Bárbara Bomfim Muniz Moraes, Henrique Cunha Vieira, Giorgio Bogani   +7 more
doaj   +1 more source

Fertility preservation healthcare circuit and networks in cancer patients worldwide: what are the issues?

BMC Cancer, 2018
Background Fertility preservation (FP) is a major determinant of quality of life after cancer remission for women who may not have achieved their ideal family size.
Kathleen Melan, Frederic Amant, Jacqueline Veronique-Baudin, Clarisse Joachim, Eustase Janky   +4 more
doaj   +1 more source

Fertility Counseling Pattern over Time in Young Patients with Breast Cancer: A Retrospective Analysis at a Large Comprehensive Cancer Center

Clinical and Experimental Obstetrics & Gynecology, 2023
Background: One main issue to be considered in young patients diagnosed with early breast cancer (BC) is the impact of oncological treatments on fertility and future chances of conception.
Caterina Barbieri, Ottavia Amato, Anna Chiara Cattelan, Loris Marin, Alessandra Andrisani, Carlo Saccardi, Tommaso Giarratano, Giovanni Faggioni, Elisabetta Di Liso, Carlo Alberto Giorgi, Eleonora Mioranza, Cristina Falci, Grazia Maria Vernaci, Roberto Tozzi, Valentina Guarneri, Maria Vittoria Dieci   +15 more
doaj   +1 more source

Longitudinal AMH trajectories, ovarian reserve recovery, and fertility outcomes after multiagent chemotherapy for high‐risk gestational trophoblastic neoplasia: A real‐world cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To characterize anti‐Müllerian hormone (AMH) recovery after multiagent chemotherapy for high‐risk gestational trophoblastic neoplasia (GTN) and evaluate the impact of regimen and hysterectomy. Methods This was a retrospective cohort of 68 high‐risk GTN patients treated with EMA/CO (etoposide, methotrexate, actinomycin D ...
Wei Xue, Tianyi Chen, Yuxiao Wu, Tong Ren, Jun Zhao, Fengzhi Feng, Xirun Wan, Yang Xiang, Junjun Yang   +8 more
wiley   +1 more source

An evaluation of oncofertility decision support resources among breast cancer patients and health care providers

BMC Health Services Research, 2019
Background Cancer patients of reproductive age are at risk of infertility as a result of their treatment. Oncofertility decision support resources can assist patients with fertility decision-making before treatment yet available oncofertility resources ...
Brittany Speller, Amanda Sissons, Corinne Daly, Marcia Facey, Erin Kennedy, Kelly Metcalfe, Nancy N. Baxter   +6 more
doaj   +1 more source

Oncofertility care for newly diagnosed girls with cancer in a national pediatric oncology setting, the first full year experience from the Princess Máxima Center, the PEARL study.

PLoS ONE, 2021
BackgroundChildhood cancer patients often remain uninformed regarding their potential risk of gonadal damage. In our hospital we introduced a five step standard oncofertility care plan for all newly diagnosed female patients aiming to identify, inform ...
M E Madeleine van der Perk, Anne-Lotte L F van der Kooi, Marianne D van de Wetering, Irene M IJgosse, Eline van Dulmen-den Broeder, Simone L Broer, Aart J Klijn, A Birgitta Versluys, Brigitte Arends, Ralph J A Oude Ophuis, Hanneke M van Santen, Alida F W van der Steeg, Margreet A Veening, Marry M van den Heuvel-Eibrink, Annelies M E Bos   +14 more
doaj   +1 more source

Disparities in Female Oncofertility Care in the United States: More Questions Than Answers

Life, 2023
As cancer therapies continue to improve, the survival rates of adolescent and young adult patients have increased. Consequently, considering patient quality of life after cancer, including family building, has become an essential aspect of establishing a
Kati A. Turner, Emily E. Spurlin, Patricia T. Jimenez   +2 more
doaj   +1 more source

Effect of an Educational Bundle on Bridging the Gap of Knowledge and Perceived Barriers regarding Oncofertility among Maternity and Oncology Nurses [PDF]

Tanta Scientific Nursing Journal
Background: The goal of oncofertility is to lessen the negative effects of cancertreatment on women 's reproductive system and fertility. Aim: The aim of thisresearch was to evaluate effect of the educational bundle on bridging the gap ofknowledge and ...
Ola Afifi Araby, Enas Abbas Badr, Mona Abd Ellatif, Nesma EL Desoky   +3 more
doaj   +1 more source

Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe

JCO Global Oncology, 2020
Purpose In the accompanying article, “Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe,” we showed that specific fertility preservation services may not be offered at various sites around the world because of ...
Alexandra S. Rashedi, Saskia F. de Roo, Lauren M. Ataman, Maxwell E. Edmonds, Adelino Amaral Silva, Anibal Scarella, Anna Horbaczewska, Antoinette Anazodo, Ayse Arvas, Bruno Ramalho de Carvalho, Cassio Sartorio, Catharina C.M. Beerendonk, Cesar Diaz-Garcia, Chang Suk Suh, Cláudia Melo, Claus Yding Andersen, Eduardo Motta, Ellen M. Greenblatt, Ellen Van Moer, Elnaz Zand, Fernando M. Reis, Flor Sánchez, Guillermo Terrado, Jhenifer K. Rodrigues, Joao Marcos de Meneses e Silva, Johan Smitz, Jose Medrano, Jung Ryeol Lee, Katharina Winkler-Crepaz, Kristin Smith, Lígia Helena Ferreira Melo e Silva, Ludwig Wildt, Mahmoud Salama, María del Mar Andrés, Maria T. Bourlon, Mario Vega, Maurício Barbour Chehin, Michel De Vos, Mohamed Khrouf, Nao Suzuki, Osama Azmy, Paula Fontoura, Paulo Henrique Almeida Campos-Junior, Peter Mallmann, Ricardo Azambuja, Ricardo M. Marinho, Richard A. Anderson, Robert Jach, Roberto de A. Antunes, Rod Mitchell, Rouhollah Fathi, Satish Kumar Adiga, Seido Takae, Seok Hyun Kim, Sergio Romero, Silvana Chedid Grieco, Talya Shaulov, Tatsuro Furui, Teresa Almeida-Santos, Willianne Nelen, Yasmin Jayasinghe, Yodo Sugishita, Teresa K. Woodruff   +62 more
doaj   +1 more source

Genetic Spectrum of Cholestasis in Tunisia and Diagnostic Yield of Next‐Generation Sequencing: Case Series of 70 Patients

Clinical Genetics, EarlyView.
Genetic hepatic cholestasis: NGS diagnostic yield. Over a 10‐year period, NGS (gene panel/WES) established a genetic diagnosis in 70% of 66 families with hepatic cholestasis, with a molecular yield of 62%. ABCB11 was the most mutated gene, and PFIC Type 2 was the leading diagnosis, underscoring the critical role of NGS in guiding genetic counseling and
Amal Abdmouleh, Houweyda Jilani, Imen Rejeb, Syrine Hizem, Nicolas Pottier, Romain Larrue, Wendy Arondal, Lucie Hanquet, Rania Benrabeh, Olfa Bouyahia, Sonia Mazigh, Yasmina Elaribi, Lamia Benjemaa   +12 more
wiley   +1 more source